An Engineered Human-Antibody Fragment with Fentanyl Pan-Specificity that Reverses Carfentanil-Induced Respiratory Depression
L. M. Eubanks, T. Pholcharee, D. Oyen, Y. Natori, B. Zhou, I. A. Wilson, K. D. Janda
This paper develops a human antibody fragment that reverses carfentanil-induced respiratory depression by targeting multiple opioid analogs.
bioRxiv · Jul 4, 2023Pharmacology & Toxicology